Desloratadine/pseudoephedrine

Desloratadine/pseudoephedrine
Combination of
DesloratadineAntihistamine
PseudoephedrineDecongestant
Clinical data
Trade namesClarinex-D, Aerinaze
AHFS/Drugs.comMicromedex Detailed Consumer Information
License data
Routes of
administration		By mouth
ATC code
Legal status
Legal status
Identifiers
CAS Number
KEGG

Desloratadine/pseudoephedrine, sold under the brand name Clarinex-D among others, is a medication used for the treatment of seasonal allergic rhinitis.[1][2]

Desloratadine/pseudoephedrine was approved for use in the United States in 2005[1][3] and in the European Union in July 2007.[2]

Medical uses

Desloratadine/pseudoephedrine is indicated for the symptomatic treatment of seasonal allergic rhinitis when accompanied by nasal congestion.[2]

References

  1. ^ a b c "Clarinex-D 12 Hour- desloratadine and pseudoephedrine sulfate tablet, extended release". DailyMed. 15 March 2019. Archived from the original on 16 February 2020. Retrieved 1 March 2020.
  2. ^ a b c d "Aerinaze EPAR". European Medicines Agency. 3 August 2007. Archived from the original on 2 March 2020. Retrieved 1 March 2020.
  3. ^ "Drug Approval Package: Clarinex-D 24 Hour (Desloratadine/Pseudoephedrine Sulfate) NDA #021605". U.S. Food and Drug Administration (FDA). 9 May 2007. Archived from the original on 2 March 2020. Retrieved 1 March 2020.

Further reading


This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.